Login / Signup

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.

Bo Jan NoordmanJoel ShapiroManon C W SpaanderKausilia K KrishnadathHanneke Wilma Marlies van LaarhovenMark Ivo van Berge HenegouwenGrard A P NieuwenhuijzenRichard van HillegersbergMeindert N SosefEwout Willem SteyerbergBas P L WijnhovenJ Jan B van Lanschotnull null
Published in: JMIR research protocols (2015)
Netherlands Trial Register: NTR4834; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4834 (archived by Webcite at http://www.webcitation.org/6Ze7mn67B).
Keyphrases
  • rectal cancer
  • phase iii
  • locally advanced
  • clinical trial
  • study protocol
  • phase ii
  • randomized controlled trial
  • lymph node
  • open label
  • squamous cell carcinoma
  • radiation therapy
  • metal organic framework